.jpg)
The Q2 report that Novo Nordisk introduced on Wednesday afternoon is impressive, to say the least.
This is according to Søren Løntoft Hansen, who is senior equity analyst at the Danish bank Sydbank.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP recommends nine new drugs, rejects one
Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.
WS Audiology still chewing over listing of online hearing company
The hearing giant is still mulling over the independent listing of Hear.com.
CEO at WSA: No clarity on EQT exit plans yet
The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.
Oticon: Covid-19 led to debates about product launches
The unpredictable world situation in the spring of 2020 meant that the timing of product launches was frequently discussed at Demant-owned Oticon, located in Denmark.
EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry
With a budget potentially exceeding EUR 47.1bn (DKK 350bn), the EU Commission wants to establish a new agency to ward against future health crises. While the financial makeup is uncertain, good news for future clinical trials might be on the way.
Associate Director, PV QA - Y-mAbs Therapeutics 
QA Specialist wanted 
Clinical Research Specialist, Post Market Clinical Development - Ambu 
Scientist, Adcendo ApS 
KLIFO is looking for a talented Medical Writer (DK, SE or DE) 
Evaxion Biotech Careers 
Medical Scientific Liaison Dermo aesthetic, IBSA 
Senior Drug Product Specialist - Zealand Pharma 
Global Senior Medical Advisor – Neurology Pipeline Projects, Lundbeck 
Senior Downstream Scientist - Symphogen 
Associate Director/Senior Manager, Global Regulatory Affairs Project Lead - Genmab 
Scientific Advisor infectious disease - Vaccibody